86 related articles for article (PubMed ID: 3219244)
21. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
Shimizu K; Ushio Y; Hayakawa T; Mogami H
Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats.
Huang TY; Arita N; Ushio Y; Hayakawa T; Yamada K
J Neurooncol; 1994; 19(3):245-50. PubMed ID: 7807175
[TBL] [Abstract][Full Text] [Related]
24. [Combination therapy with HU IFN-beta and ACNU against malignant brain tumors, Part 1. Experimental study in vitro].
Yoshida J; Wakabayashi T; Inoue I; Kageyama N
Gan To Kagaku Ryoho; 1985 Jan; 12(1):99-104. PubMed ID: 3855355
[TBL] [Abstract][Full Text] [Related]
25. Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
Izumoto S; Arita N; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Ushio Y
Anticancer Res; 1990; 10(3):735-9. PubMed ID: 2369088
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism and overcoming of resistance in ACNU-resistant sublines of rat brain tumors].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2751-7. PubMed ID: 3463247
[TBL] [Abstract][Full Text] [Related]
27. [Experimental studies on induced hypertension chemotherapy of intracerebral inoculated gliomas in rats].
Tokuda K
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):612-20. PubMed ID: 3463530
[TBL] [Abstract][Full Text] [Related]
28. [New developments in chemotherapy for experimental brain metastasis].
Kobayashi T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):757-65. PubMed ID: 3157350
[TBL] [Abstract][Full Text] [Related]
29. [Histopathological and autoradiographical studies of experimental brain tumors after continuous local chemotherapy--acute stage in rat models].
Shimura T; Teramoto A; Aihara K
Gan To Kagaku Ryoho; 1997 Apr; 24(6):713-8. PubMed ID: 9126309
[TBL] [Abstract][Full Text] [Related]
30. [Experimental studies on drug uptake by metastatic liver tumor after intra-arterial, intraportal and intravenous administration of BrdU].
Shioaki Y; Taniguchi H; Itoh A; Daidoh T; Seiki K; Yamaguchi T; Sawai K; Takahashi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2829-32. PubMed ID: 2782892
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of single-bolus vs. frequent low-dose treatment with nitrosourea in experimental gliomas.
Wu CM; Inamura T; Ikezaki K; Nakamizo A; Inoha S; Yaosaka F; Fukui M
Anticancer Res; 2001; 21(3B):1835-8. PubMed ID: 11497267
[TBL] [Abstract][Full Text] [Related]
32. [Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent].
Shibuya N; Yoshida J; Kobayashi T; Kageyama N
No Shinkei Geka; 1983 Apr; 11(4):361-7. PubMed ID: 6306497
[TBL] [Abstract][Full Text] [Related]
33. Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
Mineura K; Watanabe K; Izumi I; Kowada M
J Neurooncol; 1992 Nov; 14(3):201-5. PubMed ID: 1460484
[TBL] [Abstract][Full Text] [Related]
34. [Possibility of overcoming of ACNU resistance in an ACNU-resistant subline of C6 rat glioma].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
No To Shinkei; 1986 Nov; 38(11):1065-70. PubMed ID: 3468959
[TBL] [Abstract][Full Text] [Related]
35. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
[TBL] [Abstract][Full Text] [Related]
36. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model.
Schabet M; Ohneseit P; Buchholz R; Santo-Höltje L; Schmidberger H
J Neurooncol; 1992 Oct; 14(2):169-75. PubMed ID: 1432039
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of ACNU cytotoxicity by pretreatment with O6-methylguanine in ACNU-resistant brain tumors.
Mineura K; Izumi I; Watanabe K; Kowada M
J Neurooncol; 1994; 19(1):51-9. PubMed ID: 7815104
[TBL] [Abstract][Full Text] [Related]
39. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
[TBL] [Abstract][Full Text] [Related]
40. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
Yoshida T; Shimizu K; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Feb; 15(2):143-9. PubMed ID: 3470626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
